FPF
ONC

FNY Partners Fund’s BeOne Medicines Ltd ONC Stock Holding History

FNY Partners Fund’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-250
Closed -$25K – 635
2017
Q3 		$25K Buy
+250
New +$18.6K ﹤0.01% 358

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

FNY Partners Fund's ONC Position: Q4 2017 in Review

FNY Partners Fund sold out of BeOne Medicines Ltd (ONC) in Q4 2017, closing a stake of 250 shares — an estimated $25K sold.

FNY Partners Fund first reported a position in ONC in Q3 2017 and held it in 1 quarter. The position peaked at $25K in Q3 2017. 93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.

  • FNY Partners Fund reported no remaining BeOne Medicines Ltd position as of Q4 2017 after selling out during the quarter.
  • FNY Partners Fund sold 250 BeOne Medicines Ltd shares in Q4 2017, an estimated $25K.
  • FNY Partners Fund first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 1 quarter.
  • FNY Partners Fund's BeOne Medicines Ltd position peaked at $25K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.